Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke
Status:
NOT_YET_RECRUITING
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
This is a a clinical trial. The purpose of this study is to preliminarily explore the optimal dosage of Xinglou Chengqi Granules in the treatment of acute ischemic stroke and to evaluate the efficacy and safety of Xinglou Chengqi Granules for acute ischemic stroke.